The Securities and Exchange Commission today filed settled charges against Houston-based biotherapeutics company Kiromic BioPharma, Inc., its former CEO, Maurizio Chiriva-Internati, and its former chief financial officer, Tony Tontat, for failing to…
More information at SECLaw.com Read the Full Press Release
Have a securities law question? Call New York Securities Lawyers at 212-509-6544.